In a 26-week phase 2 study involving patients with obesity and T2DM, treatment with tirzepatide dose-dependently decreased the circulating levels of specific biomarkers of inflammation and endothelial dysfunction previously associated with cardiovascular events, suggesting a net improvement in the cardiovascular risk profile of these patients.37 In this post hoc analysis, inflammation, endothelial dysfunction, and cellular stress biomarkers were measured at baseline and 4, 12, and 26 weeks to evaluate the additional effects of tirzepatide on cardiovascular risk factors.37 After 26 weeks, tirzepatide treatment at doses of 10 and 15 mg decreased the levels of YKL-40 (also known as chitinase-3 like-protein-1), intercellular adhesion molecule 1 (ICAM-1), leptin, and growth differentiation factor 15 compared with baseline
doi: 10.1038/modpathol.2014.113 83 HegedsLShermanSITuttleRMvon ScholtenBJRasmussenSKarsblJDet al
For patients like Sarah, these injections can lead to significant improvements in weight, energy, and overall quality of life
Semaglutide slows stomach emptying and increases fullness signals in the brain, making large, fatty, or sugary meals physically difficult to process
Online services often lack proper follow-ups , which can result in ineffective dosing or unaddressed side effects
Branded semaglutide (Ozempic, Wegovy) does not contain B12 only certain compounded formulas do, and the rules around compounding changed in 2025